The anti-tumoral drug enzastaurin inhibits natural killer cell cytotoxicity via activation of glycogen synthase kinase-3β.
- DOI
- 10.1016/j.bcp.2010.09.026
- Published
- 2011 Jan 15
- Container
- Biochemical pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bcp.2010.09.026,
title = {The anti-tumoral drug enzastaurin inhibits natural killer cell cytotoxicity via activation of glycogen synthase kinase-3β.},
author = {Ogbomo H and Biru T and Michaelis M and Loeschmann N and Doerr HW and Cinatl J Jr},
year = {2011},
journal = {Biochemical pharmacology},
doi = {10.1016/j.bcp.2010.09.026},
url = {https://doi.org/10.1016/j.bcp.2010.09.026}
}RIS
TY - JOUR TI - The anti-tumoral drug enzastaurin inhibits natural killer cell cytotoxicity via activation of glycogen synthase kinase-3β. AU - Ogbomo H AU - Biru T AU - Michaelis M AU - Loeschmann N AU - Doerr HW AU - Cinatl J Jr PY - 2011 JO - Biochemical pharmacology DO - 10.1016/j.bcp.2010.09.026 UR - https://doi.org/10.1016/j.bcp.2010.09.026 ER -
APA
H, O., T, B., M, M., N, L., HW, D., & Jr, C. J. (2011). The anti-tumoral drug enzastaurin inhibits natural killer cell cytotoxicity via activation of glycogen synthase kinase-3β.. Biochemical pharmacology. https://doi.org/10.1016/j.bcp.2010.09.026
Source records
- pubmed · retrieved 2026-09-25T04:28:44.984Z